Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5508491> ?p ?o }
Showing triples 1 to 51 of
51
with 100 triples per page.
- Q5508491 subject Q13245314.
- Q5508491 subject Q7162167.
- Q5508491 subject Q8522217.
- Q5508491 subject Q9052323.
- Q5508491 abstract "Fulvestrant (trade name Faslodex, by AstraZeneca) is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is a complete estrogen receptor antagonist with no agonist effects, which in addition, accelerates the proteasomal degradation of the estrogen receptor. The drug has poor oral bioavailability, and is administered monthly via intramuscular injection.".
- Q5508491 atcPrefix "L02".
- Q5508491 atcSuffix "BA03".
- Q5508491 casNumber "129453-61-8".
- Q5508491 chEBI "31638".
- Q5508491 drugbank "DB00947".
- Q5508491 fdaUniiCode "22X328QOC4".
- Q5508491 iupacName "(7α,17β)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol".
- Q5508491 pubchem "104741".
- Q5508491 thumbnail Fulvestrant.svg?width=300.
- Q5508491 wikiPageExternalLink faslodex.pdf.
- Q5508491 wikiPageExternalLink www.faslodex.com.
- Q5508491 wikiPageWikiLink Q12140.
- Q5508491 wikiPageWikiLink Q128581.
- Q5508491 wikiPageWikiLink Q13245314.
- Q5508491 wikiPageWikiLink Q16251481.
- Q5508491 wikiPageWikiLink Q177708.
- Q5508491 wikiPageWikiLink Q194974.
- Q5508491 wikiPageWikiLink Q309110.
- Q5508491 wikiPageWikiLink Q3425168.
- Q5508491 wikiPageWikiLink Q410943.
- Q5508491 wikiPageWikiLink Q412178.
- Q5508491 wikiPageWikiLink Q416496.
- Q5508491 wikiPageWikiLink Q419143.
- Q5508491 wikiPageWikiLink Q432083.
- Q5508491 wikiPageWikiLink Q461809.
- Q5508491 wikiPageWikiLink Q7162167.
- Q5508491 wikiPageWikiLink Q731938.
- Q5508491 wikiPageWikiLink Q8522217.
- Q5508491 wikiPageWikiLink Q903917.
- Q5508491 wikiPageWikiLink Q9052323.
- Q5508491 atcPrefix "L02".
- Q5508491 atcSuffix "BA03".
- Q5508491 casNumber "129453".
- Q5508491 chebi "31638".
- Q5508491 drugbank "DB00947".
- Q5508491 iupacName "-7".
- Q5508491 pubchem "104741".
- Q5508491 unii "22".
- Q5508491 type ChemicalSubstance.
- Q5508491 type Drug.
- Q5508491 type ChemicalObject.
- Q5508491 type Thing.
- Q5508491 type Q8386.
- Q5508491 comment "Fulvestrant (trade name Faslodex, by AstraZeneca) is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is a complete estrogen receptor antagonist with no agonist effects, which in addition, accelerates the proteasomal degradation of the estrogen receptor. The drug has poor oral bioavailability, and is administered monthly via intramuscular injection.".
- Q5508491 label "Fulvestrant".
- Q5508491 depiction Fulvestrant.svg.